
Cassel Salpeter & Co.’s Q3 healthcare update points to disrupted NIH grant processing, FDA attrition, and tariffs as pressures on drug development and early-stage financing.
Diabetes & Obesity Series
Subscribe to RSS feed of this series
John Buse, MD, PhD, CDEDirector Diabetes Care Center
Chief of the Endocrinology Division
University of North Carolina School of Medicine
President, Medicine & Science
American Diabetes Association
Dr. Buse continues his discussion on what impact diabetes trials has on study staff, as well as the challenges to subject recruitment and retention.
Others in the Series
Associations and Societies
Clinical Trials
Articles, Multimedia
Associations and Societies
Clinical Trials






